| Value | ₹20.40 Cr |
|---|---|
| Execution period | Vesting on 01.09.2032 (Class A) and 01.09.2029 (Class B); Exercise period 3 months from vesting. |
BSE filing, NSE: DMART. Summary written from the filing by ALFA Finder's alert engine.
Avenue Supermarts Ltd: key numbers
- Share price
- ₹3,175.00
- Market cap
- ₹2,07,108 Cr
- Revenue (annual)
- ₹68,821 Cr
- Net profit (annual)
- ₹2,970 Cr
- P/E (TTM)
- 66.5×Sector 61.5×
- Promoter holding
- 74.48%+0.00% QoQ
- FII holding
- 8.48%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Avenue Supermarts Ltd
All →Avenue Supermarts Debt & Borrowing: ₹200 Cr
Avenue Supermarts allotted Rs 200 crore of unsecured commercial paper on 29 October 2026, maturing 11 December 2026 at 7.20% coupon. The paper carries an ICRA A1+ rating and is proposed to be listed on BSE.
- Value
- ₹200.0 Cr
- Execution
- 43 days
Avenue Supermarts Other Announcement
Avenue Supermarts disclosed PIT Reg 7(2) trades by designated persons, mainly pledge invocations to repay ESOP loans. Aggregate disclosed value is about Rs 2.24 Crore.
- Value
- ₹2.24 Cr
Avenue Supermarts Legal & Regulatory
Avenue Supermarts was penalised Rs.55.75 lakhs by GIFT City authority for project completion delays. The company is evaluating the penalty letter and says operations are unaffected.
- Value
- ₹0.56 Cr
Avenue Supermarts Other Announcement
Avenue Supermarts disclosed two designated persons' pledge invocations to repay ESOP exercise loans. Shares disposed on 22 October 2026 were worth a combined Rs.1.89 Crore.
- Value
- ₹1.89 Cr
Avenue Supermarts Other Announcement
Avenue Supermarts disclosed insider trading filings involving designated persons. These disclosures detail recent market sales and pledge invocations of equity shares.
- Value
- ₹0.46 Cr
Avenue Supermarts Other Announcement
Designated persons of Avenue Supermarts Ltd disclosed transactions involving pledge creation and invocation for equity shares, totaling ₹5.29 Crore in value.
- Value
- ₹5.29 Cr
Other employee stock options announcements
All →Strides Pharma Science Employee Stock Options
Strides Pharma allotted 7,500 equity shares to an employee exercising options under the Strides ESOP 2016 Plan. Paid-up capital rises to 92,180,214 shares.
Shaily Engineering Plastics Employee Stock Options
Shaily Engineering Plastics allotted 1,300 equity shares to employees on exercise of ESOPs at Rs. 732 per share under its 2019 plan. Issued paid-up capital rises to 4,59,96,548 shares of Rs. 2 each.
Info Edge (India) Employee Stock Options
Info Edge's employee stock option trust sold 1,439 shares on 26 October 2026 under the ESOP scheme. The disposal reduces the trust's holding to 410,707 shares.
Motilal Oswal Financial Services Employee Stock Options
Motilal Oswal Financial Services granted 2,20,000 stock options to eligible employees under its ESOP Scheme X. No exercise price or monetary value is disclosed.
Borosil Employee Stock Options
Borosil granted 7,23,200 employee stock options at Rs 192.8 each under its 2020 scheme. Options vest in three tranches over three years.
- Execution
- Vesting over 3 years from grant date
Natco Pharma Employee Stock Options
Natco Pharma's insiders, including promoters and directors, were allotted equity shares. This allotment increases their total shareholding in the company.
- Value
- ₹144.2 Cr